mobile btn
Friday, December 3rd, 2021

ECBC deploys team for testing at Yuma Proving Ground Site

The U.S. Army Edgewood Chemical Biological Center (ECBC) announced on Thursday that it had dispatched a team to the Sonoran Desert for a project supporting the U.S. Army Corps of Engineers, Engineering and Support Center, Huntsville Center, and the U.S. Army Yuma Proving Ground (YPG). The YPG... Read More »

NIAID exercises option for RiVax

Soligenix, Inc., announced on Wednesday that the National Institute of Allergy and Infectious Diseases (NIAID) has exercised its option to accelerate the regulatory activities with the U.S. Food and Drug Administration (FDA) for Soligenix's heat stable ricin toxin vaccine RiVax. The NIAID’s... Read More »

WHO commends Sierra Leone’s Ebola response

The World Health Organization announced on Thursday that 42 days have passed since the last person confirmed to have Ebola virus disease in Sierra Leone tested negative for a second time. “Today marks another milestone in the country’s effort to defeat Ebola,” the WHO said. “WHO... Read More »

McCaul releases March terrorism threat snapshot

House Homeland Security Committee Chairman Michael McCaul (R-TX) on Tuesday released a monthly assessment on terror threats that face the United States and its allies. “This week’s Islamist terror plots in Canada and Europe are a grim reminder of the heightened threat environment America... Read More »

DHS announces new funding opportunities for FY 2016

The U.S. Department of Homeland Security (DHS) announced more than $1.6 billion on Monday for 10 DHS preparedness grants programs as part of the release of a FY 2016 Notices of Funding Opportunity. Funding will be provided to state, local tribal and territorial governments, along with... Read More »

NIH seeking ID of therapeutic lead compounds

The National Institutes of Health announced last week that it is aiming to develop new and improved therapeutics to treat injuries from exposure to chemical threats. The grant is entitled the “Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead... Read More »